Brandelyn N. Pitcher

2.8k total citations
37 papers, 1.3k citations indexed

About

Brandelyn N. Pitcher is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Brandelyn N. Pitcher has authored 37 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pathology and Forensic Medicine, 17 papers in Oncology and 13 papers in Genetics. Recurrent topics in Brandelyn N. Pitcher's work include Lymphoma Diagnosis and Treatment (17 papers), Chronic Lymphocytic Leukemia Research (11 papers) and Cardiac, Anesthesia and Surgical Outcomes (6 papers). Brandelyn N. Pitcher is often cited by papers focused on Lymphoma Diagnosis and Treatment (17 papers), Chronic Lymphocytic Leukemia Research (11 papers) and Cardiac, Anesthesia and Surgical Outcomes (6 papers). Brandelyn N. Pitcher collaborates with scholars based in United States, Switzerland and Germany. Brandelyn N. Pitcher's co-authors include Bruce D. Cheson, Nancy L. Bartlett, Sin‐Ho Jung, John P. Leonard, Kristie A. Blum, Clifford A. Hudis, Eric P. Winer, Myron S. Czuczman, Eric D. Hsi and Scott E. Smith and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Brandelyn N. Pitcher

35 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brandelyn N. Pitcher United States	19	810	587	373	267	219	37	1.3k
Eliza A. Hawkes Australia	20	847 1.0×	1.0k 1.7×	382 1.0×	122 0.5×	230 1.1×	133	1.6k
Tara Baetz Canada	20	904 1.1×	514 0.9×	261 0.7×	105 0.4×	391 1.8×	71	1.5k
Susan E. O’Reilly Canada	12	658 0.8×	534 0.9×	234 0.6×	231 0.9×	219 1.0×	15	1.1k
Reem Karmali United States	17	559 0.7×	647 1.1×	192 0.5×	92 0.3×	130 0.6×	116	1.0k
Lucia Nogová Germany	24	683 0.8×	698 1.2×	184 0.5×	154 0.6×	642 2.9×	86	1.5k
Robert C. Hermann United States	15	1.0k 1.2×	449 0.8×	284 0.8×	178 0.7×	868 4.0×	38	1.8k
Serge Bologna France	16	607 0.7×	1.1k 1.8×	288 0.8×	65 0.2×	343 1.6×	38	1.4k
B.Y. Yeap United States	20	805 1.0×	595 1.0×	295 0.8×	238 0.9×	1.0k 4.6×	65	2.0k
Sirkku Jyrkkiö Finland	15	538 0.7×	240 0.4×	150 0.4×	275 1.0×	180 0.8×	48	1.1k
Juliana Di Iulio Australia	16	645 0.8×	314 0.5×	254 0.7×	81 0.3×	223 1.0×	34	1.1k

Countries citing papers authored by Brandelyn N. Pitcher

Since Specialization

Citations

This map shows the geographic impact of Brandelyn N. Pitcher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brandelyn N. Pitcher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brandelyn N. Pitcher more than expected).

Fields of papers citing papers by Brandelyn N. Pitcher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brandelyn N. Pitcher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brandelyn N. Pitcher. The network helps show where Brandelyn N. Pitcher may publish in the future.

Co-authorship network of co-authors of Brandelyn N. Pitcher

This figure shows the co-authorship network connecting the top 25 collaborators of Brandelyn N. Pitcher. A scholar is included among the top collaborators of Brandelyn N. Pitcher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brandelyn N. Pitcher. Brandelyn N. Pitcher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lasala, Javier, Gabriel E. Mena, Maria D. Iniesta, et al.. (2021). Impact of anesthesia technique on post-operative opioid use in open gynecologic surgery in an enhanced recovery after surgery pathway. International Journal of Gynecological Cancer. 31(4). 569–574. 3 indexed citations

Meyer, Larissa A., Maria D. Iniesta, Mark F. Munsell, et al.. (2020). A prospective randomized trial comparing liposomal bupivacaine vs standard bupivacaine wound infiltration in open gynecologic surgery on an enhanced recovery pathway. American Journal of Obstetrics and Gynecology. 224(1). 70.e1–70.e11. 16 indexed citations

Thanarajasingam, Gita, John P. Leonard, Thomas E. Witzig, et al.. (2020). Longitudinal Toxicity over Time (ToxT) analysis to evaluate tolerability: a case study of lenalidomide in the CALGB 50401 (Alliance) trial. The Lancet Haematology. 7(6). e490–e497. 17 indexed citations

Iniesta, Maria D., Brandelyn N. Pitcher, Pedro T. Ramírez, et al.. (2020). Enhanced recovery for obese patients undergoing gynecologic cancer surgery. International Journal of Gynecological Cancer. 30(10). 1595–1602. 5 indexed citations

Guzman, Alexis B., Brandelyn N. Pitcher, Andrea Rodríguez-Restrepo, et al.. (2019). Impact of implementation of an enhanced recovery program in gynecologic surgery on healthcare costs. American Journal of Obstetrics and Gynecology. 222(1). 66.e1–66.e9. 21 indexed citations

Iniesta, Maria D., Javier Lasala, Gabriel E. Mena, et al.. (2019). Impact of compliance with an enhanced recovery after surgery pathway on patient outcomes in open gynecologic surgery. International Journal of Gynecological Cancer. 29(9). 1417–1424. 31 indexed citations

Magbanua, Mark Jesus M., Hope S. Rugo, Denise M. Wolf, et al.. (2018). Expanded Genomic Profiling of Circulating Tumor Cells in Metastatic Breast Cancer Patients to Assess Biomarker Status and Biology Over Time (CALGB 40502 and CALGB 40503, Alliance). Clinical Cancer Research. 24(6). 1486–1499. 36 indexed citations

Salcedo, Mila Pontremoli, Anil K. Sood, Ricardo dos Reis, et al.. (2018). Perineural invasion (PNI) in vulvar carcinoma: A review of 421 cases. Gynecologic Oncology. 152(1). 101–105. 18 indexed citations

Straus, David J., Sin‐Ho Jung, Brandelyn N. Pitcher, et al.. (2018). CALGB 50604: risk-adapted treatment of nonbulky early-stage Hodgkin lymphoma based on interim PET. Blood. 132(10). 1013–1021. 65 indexed citations

10.

Smith, Sonali M., Sonali M. Smith, Brandelyn N. Pitcher, et al.. (2017). Safety and tolerability of idelalisib, lenalidomide, and rituximab in relapsed and refractory lymphoma: the Alliance for Clinical Trials in Oncology A051201 and A051202 phase 1 trials. The Lancet Haematology. 4(4). e176–e182. 63 indexed citations

11.

Martin, Peter W., Sin‐Ho Jung, Brandelyn N. Pitcher, et al.. (2017). A phase II trial of lenalidomide plus rituximab in previously untreated follicular non-Hodgkin’s lymphoma (NHL): CALGB 50803 (Alliance). Annals of Oncology. 28(11). 2806–2812. 55 indexed citations

12.

Kimmick, Gretchen, Brittny Major, Jonathan D. Clapp, et al.. (2017). Using ePrognosis to estimate 2-year all-cause mortality in older women with breast cancer: Cancer and Leukemia Group B (CALGB) 49907 and 369901 (Alliance A151503). Breast Cancer Research and Treatment. 163(2). 391–398. 12 indexed citations

13.

Wilson, Wyndham H., Brandelyn N. Pitcher, Eric D. Hsi, et al.. (2016). Phase III Randomized Study of R-CHOP Versus DA-EPOCH-R and Molecular Analysis of Untreated Diffuse Large B-Cell Lymphoma: CALGB/Alliance 50303. Blood. 128(22). 469–469. 70 indexed citations

14.

Mandelblatt, Jeanne S., Jonathan D. Clapp, George Luta, et al.. (2016). Long‐term trajectories of self‐reported cognitive function in a cohort of older survivors of breast cancer: CALGB 369901 (Alliance). Cancer. 122(22). 3555–3563. 68 indexed citations

15.

Carey, Lisa A., Donald A. Berry, Constance Cirrincione, et al.. (2015). Molecular Heterogeneity and Response to Neoadjuvant Human Epidermal Growth Factor Receptor 2 Targeting in CALGB 40601, a Randomized Phase III Trial of Paclitaxel Plus Trastuzumab With or Without Lapatinib. Journal of Clinical Oncology. 34(6). 542–549. 263 indexed citations

16.

Ujjani, Chaitra S., Brandelyn N. Pitcher, Peter Martin, et al.. (2015). Phase I Study of Rituximab, Lenalidomide, and Ibrutinib in Previously Untreated Follicular Lymphoma (Alliance 051103). Blood. 126(23). 471–471. 4 indexed citations

17.

Du, Juan, Sandra López‐Vergès, Brandelyn N. Pitcher, et al.. (2014). CALGB 150905 (Alliance): Rituximab Broadens the Antilymphoma Response by Activating Unlicensed NK Cells. Cancer Immunology Research. 2(9). 878–889. 44 indexed citations

18.

Sheppard, Vanessa B., Leigh Anne Faul, George Luta, et al.. (2014). Frailty and Adherence to Adjuvant Hormonal Therapy in Older Women With Breast Cancer: CALGB Protocol 369901. Journal of Clinical Oncology. 32(22). 2318–2327. 69 indexed citations

19.

Morrison, Vicki A., Sin‐Ho Jung, Jeffrey L. Johnson, et al.. (2014). Therapy with bortezomib plus lenalidomide for relapsed/refractory mantle cell lymphoma: final results of a phase II trial (CALGB 50501). Leukemia & lymphoma. 56(4). 958–964. 33 indexed citations

20.

Freedman, Rachel A., Brandelyn N. Pitcher, Nancy L. Keating, et al.. (2013). Cognitive function in older women with breast cancer treated with standard chemotherapy and capecitabine on Cancer and Leukemia Group B 49907. Breast Cancer Research and Treatment. 139(2). 607–616. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact